A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults ...

Is Soda Bad for You? We don’t love labeling foods and beverages “good” or “bad” — not even soda. This sort of black-and-white thinking doesn’t do ...

Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk ・Combines Mount Sinai’s world-class AI and ...

For the first time in the decade that homeless mortality has been tracked in Los Angeles County, fewer people have died on the streets and in shelters, the Department of Public Health reported Tuesday ...

The private placement is led by Coastlands Capital, with participation from Janus Henderson Investors, along with Logos Capital and Kalehua Capital, for total gross proceeds in the initial closing of ...

Early intervention in childhood obesity can significantly reduce future health risks and promote sustainable weight management before age ten.

A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults with heart disease. Harnessing cellular therapies, the company aims to ...

Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Approved dosing regimen reduces the burden for eligible patients, their families, and the broader healthcare system by extending infusion interval from every-two-weeks to every-four-weeks for those st ...

Emerging research links the gut microbiome to heart health. Beneficial bacteria may protect the heart, while others increase ...

Cardiol Therapeutics (NASDAQ:CRDL) used a presentation at TD Cowen’s 46th Annual Healthcare Conference to outline its clinical development programs targeting inflammation in cardiac disease, with its ...

Genetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 Million in Upfront Payments in Addition to Research Funding and Milestone ...